James and Carol Collins.
The David Geffen School of Medicine at UCLA has established the Switzer Prize, an international award that recognizes excellence in basic-science research. The prize is named in honor of Irma and Norman Switzer, who made a landmark bequest of $50 million to the David Geffen School of Medicine at UCLA in 2014. The school created a fund to advance medicine and health, and as a tribute to the Switzers, the UCLA Center for the Health Sciences Plaza was renamed the Irma and Norman Switzer Plaza.
The Switzer Prize honors scientists who have made revolutionary discoveries in the basic biological and biomedical sciences that have the potential to transform the understanding of health and disease. Nominations are open to national and international candidates from any institution and may be made by individuals or institutions. “I am delighted to institute the Switzer Prize because basic biomedical research is critical to the mission of the David Geffen School of Medicine at UCLA,” said Dr. Kelsey C. Martin, dean of the David Geffen School of Medicine at UCLA. Dr. Kathrin Plath, professor of biological chemistry, will chair the Switzer Prize selection committee.
The recipient of the 2017 Switzer Prize, to be named in spring 2017, will receive a $25,000 honorarium and deliver the first annual Switzer Prize lecture at the David Geffen School of Medicine at UCLA in fall 2017.
For more information, contact Chelsea Bollea at: (310) 825-5328